Phase 1 superpotent melanotropin
First human clinical evaluation of MT-II tanning response and safety.
Reproducible increase in melanin density with manageable side-effect profile.

Synthetic α-MSH analogue for melanocortin-system research.
Melanotan 2 is a cyclic synthetic analogue of α-melanocyte-stimulating hormone used in research of melanocortin receptors and pigmentation pathways.
Non-selective melanocortin receptor agonist (MC1R, MC3R, MC4R, MC5R) influencing melanogenesis and central appetite/arousal pathways.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
First human clinical evaluation of MT-II tanning response and safety.
Reproducible increase in melanin density with manageable side-effect profile.
Tested MT-II on erectile response in psychogenic ED population.
Significant erectile response vs. placebo confirming central MC4R activity.
Historical and commercial review of melanocortin peptide therapeutics.
Established pan-MCR class as productive research/clinical pathway.
Lyophilized -20°C, light-protected.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — Melanotan 2 (MT-2) is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.